Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 377
Filter
Add more filters

Complementary Medicines
Publication year range
1.
Mol Cell Neurosci ; 126: 103883, 2023 09.
Article in English | MEDLINE | ID: mdl-37527694

ABSTRACT

There is growing interest in the use of natural products for the treatment of Parkinson's disease (PD). Mucuna pruriens has been used in the treatment of humans with PD. The goal of this study was to determine if daily oral treatment with an extract of Mucuna pruriens, starting after the MPTP-induced loss of nigrostriatal dopamine in male mice, would result in recovery/restoration of motor function, tyrosine hydroxylase (TH) protein expression in the nigrostriatal pathway, or glutamate biomarkers in both the striatum and motor cortex. Following MPTP administration, resulting in an 80 % loss of striatal TH, treatment with Mucuna pruriens failed to rescue either striatal TH or the dopamine transporter back to the control levels, but there was restoration of gait/motor function. There was an MPTP-induced loss of TH-labeled neurons in the substantia nigra pars compacta and in the number of striatal dendritic spines, both of which failed to be recovered following treatment with Mucuna pruriens. This Mucuna pruriens-induced locomotor recovery following MPTP was associated with restoration of two striatal glutamate transporter proteins, GLAST (EAAT1) and EAAC1 (EAAT3), and the vesicular glutamate transporter 2 (Vglut2) within the motor cortex. Post-MPTP treatment with Mucuna pruriens, results in locomotor improvement that is associated with recovery of striatal and motor cortex glutamate transporters but is independent of nigrostriatal TH restoration.


Subject(s)
Mucuna , Parkinson Disease , Plant Extracts , Parkinson Disease/drug therapy , Parkinson Disease/pathology , Glutamic Acid/metabolism , Biomarkers/metabolism , Motor Cortex/drug effects , Motor Cortex/metabolism , Motor Cortex/pathology , Mucuna/chemistry , Plant Extracts/administration & dosage , Gait/drug effects , Pars Compacta/metabolism , Pars Compacta/pathology , Basal Ganglia/metabolism , Basal Ganglia/pathology , Animals , Mice
2.
Cell Rep ; 35(3): 109007, 2021 04 20.
Article in English | MEDLINE | ID: mdl-33882305

ABSTRACT

Parkinson's disease is characterized by both hypokinetic and hyperkinetic symptoms. While increased subthalamic burst discharges have a direct causal relationship with the hypokinetic manifestations (e.g., rigidity and bradykinesia), the origin of the hyperkinetic symptoms (e.g., resting tremor and propulsive gait) has remained obscure. Neuronal burst discharges are presumed to be autonomous or less responsive to synaptic input, thereby interrupting the information flow. We, however, demonstrate that subthalamic burst discharges are dependent on cortical glutamatergic synaptic input, which is enhanced by A-type K+ channel inhibition. Excessive top-down-triggered subthalamic burst discharges then drive highly correlative activities bottom-up in the motor cortices and skeletal muscles. This leads to hyperkinetic behaviors such as tremors, which are effectively ameliorated by inhibition of cortico-subthalamic AMPAergic synaptic transmission. We conclude that subthalamic burst discharges play an imperative role in cortico-subcortical information relay, and they critically contribute to the pathogenesis of both hypokinetic and hyperkinetic parkinsonian symptoms.


Subject(s)
Globus Pallidus/physiopathology , Hyperkinesis/physiopathology , Motor Cortex/physiopathology , Parkinson Disease, Secondary/physiopathology , Subthalamic Nucleus/physiopathology , Tremor/physiopathology , 4-Aminopyridine/pharmacology , 6-Cyano-7-nitroquinoxaline-2,3-dione/pharmacology , Animals , Excitatory Amino Acid Agonists/pharmacology , Excitatory Amino Acid Antagonists/pharmacology , Female , Globus Pallidus/drug effects , Globus Pallidus/metabolism , Glutamic Acid/metabolism , Glutamic Acid/pharmacology , Humans , Hyperkinesis/metabolism , Male , Membrane Potentials/drug effects , Mice, Inbred C57BL , Motor Cortex/drug effects , Motor Cortex/metabolism , Muscle, Skeletal/drug effects , Muscle, Skeletal/metabolism , Muscle, Skeletal/physiopathology , Optogenetics/methods , Parkinson Disease, Secondary/metabolism , Rats , Rats, Wistar , Subthalamic Nucleus/drug effects , Subthalamic Nucleus/metabolism , Synapses/drug effects , Synapses/metabolism , Synapses/pathology , Synaptic Transmission , Tremor/metabolism , alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/pharmacology
3.
Br J Anaesth ; 126(6): 1141-1156, 2021 Jun.
Article in English | MEDLINE | ID: mdl-33641936

ABSTRACT

BACKGROUND: Both animal and retrospective human studies have linked extended and repeated general anaesthesia during early development with cognitive and behavioural deficits later in life. However, the neuronal circuit mechanisms underlying this anaesthesia-induced behavioural impairment are poorly understood. METHODS: Neonatal mice were administered one or three doses of propofol, a commonly used i.v. general anaesthetic, over Postnatal days 7-11. Control mice received Intralipid® vehicle injections. At 4 months of age, the mice were subjected to a series of behavioural tests, including motor learning. During the process of motor learning, calcium activity of pyramidal neurones and three classes of inhibitory interneurones in the primary motor cortex were examined in vivo using two-photon microscopy. RESULTS: Repeated, but not a single, exposure of neonatal mice to propofol i.p. caused motor learning impairment in adulthood, which was accompanied by a reduction of pyramidal neurone number and activity in the motor cortex. The activity of local inhibitory interneurone networks was also altered: somatostatin-expressing and parvalbumin-expressing interneurones were hypoactive, whereas vasoactive intestinal peptide-expressing interneurones were hyperactive when the mice were performing a motor learning task. Administration of low-dose pentylenetetrazol to attenuate γ-aminobutyric acid A receptor-mediated inhibition or CX546 to potentiate α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-subtype glutamate receptor function during emergence from anaesthesia ameliorated neuronal dysfunction in the cortex and prevented long-term behavioural deficits. CONCLUSIONS: Repeated exposure of neonatal mice to propofol anaesthesia during early development causes cortical circuit dysfunction and behavioural impairments in later life. Potentiation of neuronal activity during recovery from anaesthesia reduces these adverse effects of early-life anaesthesia.


Subject(s)
Anesthetics, Intravenous/toxicity , Behavior, Animal/drug effects , Maze Learning/drug effects , Motor Activity/drug effects , Motor Cortex/drug effects , Neurotoxicity Syndromes/etiology , Propofol/toxicity , Animals , Animals, Newborn , Calcium Signaling/drug effects , Elevated Plus Maze Test , Excitatory Amino Acid Agonists/pharmacology , GABA Antagonists/pharmacology , Interneurons/drug effects , Interneurons/metabolism , Mice, Transgenic , Motor Cortex/metabolism , Motor Cortex/physiopathology , Neural Inhibition/drug effects , Neurotoxicity Syndromes/physiopathology , Neurotoxicity Syndromes/prevention & control , Neurotoxicity Syndromes/psychology , Open Field Test/drug effects , Pyramidal Cells/drug effects , Pyramidal Cells/metabolism , Social Behavior
4.
Neurobiol Dis ; 153: 105318, 2021 06.
Article in English | MEDLINE | ID: mdl-33636386

ABSTRACT

Huntington's disease (HD) is a neurodegenerative disorder characterized by accumulation of mutant huntingtin protein and significant loss of neurons in striatum and cortex. Along with motor difficulties, the HD patients also manifest anxiety and loss of cognition. Unfortunately, the clinically approved drugs only offer symptomatic relief and are not free from side effects. This study underlines the importance of glyceryl tribenzoate (GTB), an FDA-approved food flavoring ingredient, in alleviating HD pathology in transgenic N171-82Q mouse model. Oral administration of GTB significantly reduced mutant huntingtin level in striatum, motor cortex as well as hippocampus and increased the integrity of viable neurons. Furthermore, we found the presence of sodium benzoate (NaB), a FDA-approved drug for urea cycle disorders and glycine encephalopathy, in the brain of GTB-fed HD mice. Accordingly, NaB administration also markedly decreased huntingtin level in striatum and cortex. Glial activation is found to coincide with neuronal death in affected regions of HD brains. Interestingly, both GTB and NaB treatment suppressed activation of glial cells and inflammation in the brain. Finally, neuroprotective effect of GTB and NaB resulted in improved motor performance of HD mice. Collectively, these results suggest that GTB and NaB may be repurposed for HD.


Subject(s)
Benzoates/administration & dosage , Flavoring Agents/pharmacology , Food Preservatives/pharmacology , Huntingtin Protein/drug effects , Huntington Disease/metabolism , Motor Cortex/drug effects , Neostriatum/drug effects , Sodium Benzoate/pharmacology , Administration, Oral , Animals , Benzoates/pharmacology , Benzoic Acid/pharmacology , Gait Analysis , Hand Strength , Humans , Huntingtin Protein/genetics , Huntingtin Protein/metabolism , Huntington Disease/genetics , Huntington Disease/physiopathology , Mice , Mice, Transgenic , Motor Cortex/metabolism , Neostriatum/metabolism , Open Field Test , Rotarod Performance Test , Sodium Benzoate/metabolism
5.
Biomed Pharmacother ; 133: 110844, 2021 Jan.
Article in English | MEDLINE | ID: mdl-33186793

ABSTRACT

Cerebral palsy (CP) is a non-progressive motor-impairment disorder related to brain injury early in development. To gain new insights into the mechanisms of CP and the therapeutic efficacy of Baimai ointment, we used a high-throughput quantitative proteomic approach to evaluate proteomic changes in the hippocampus and motor cortex in a rat model of CP induced by lipopolysaccharide (LPS) combined with hypoxia/ischemia (H/I). More than 2000 proteins were identified in each brain region with high confidence. Quantitative analysis demonstrated profound disturbances in the proteomes of the hippocampus and motor cortex after LPS + H/I, in addition to the disruption of the motor system. In contrast, the topical application of Baimai ointment not only alleviated the motor deficit in the CP model rats, but also restored the proteomes in the brain cortex. Furthermore, astrocytes in the hippocampus were strongly activated in the Baimai-treated CP rat brains, associated with an increase in neurotrophic factors. Proteomic analysis demonstrated that the CP model induced neuroinflammatory responses in the brain which were reversed by the topical application of Baimai ointment. This study highlights the unexpected roles of hippocampus and motor cortex neurons in CP progress and treatment, thus providing potentially novel therapeutic targets for CP.


Subject(s)
Behavior, Animal/drug effects , Cerebral Palsy/drug therapy , Drugs, Chinese Herbal/administration & dosage , Hippocampus/drug effects , Motor Activity/drug effects , Motor Cortex/drug effects , Proteome , Proteomics , Administration, Cutaneous , Animals , Astrocytes/drug effects , Astrocytes/metabolism , Cerebral Palsy/metabolism , Cerebral Palsy/physiopathology , Chromatography, High Pressure Liquid , Chromatography, Reverse-Phase , Disease Models, Animal , Drugs, Chinese Herbal/pharmacology , Female , Hippocampus/metabolism , Hippocampus/physiopathology , Male , Motor Cortex/metabolism , Motor Cortex/physiopathology , Neurons/drug effects , Neurons/metabolism , Ointments , Pregnancy , Rats, Sprague-Dawley , Tandem Mass Spectrometry
6.
Int J Mol Sci ; 23(1)2021 Dec 22.
Article in English | MEDLINE | ID: mdl-35008538

ABSTRACT

Mercury is a severe environmental pollutant with neurotoxic effects, especially when exposed for long periods. Although there are several evidences regarding mercury toxicity, little is known about inorganic mercury (IHg) species and cerebellum, one of the main targets of mercury associated with the neurological symptomatology of mercurial poisoning. Besides that, the global proteomic profile assessment is a valuable tool to screen possible biomarkers and elucidate molecular targets of mercury neurotoxicity; however, the literature is still scarce. Thus, this study aimed to investigate the effects of long-term exposure to IHg in adult rats' cerebellum and explore the modulation of the cerebellar proteome associated with biochemical and functional outcomes, providing evidence, in a translational perspective, of new mercury toxicity targets and possible biomarkers. Fifty-four adult rats were exposed to 0.375 mg/kg of HgCl2 or distilled water for 45 days using intragastric gavage. Then, the motor functions were evaluated by rotarod and inclined plane. The cerebellum was collected to quantify mercury levels, to assess the antioxidant activity against peroxyl radicals (ACAPs), the lipid peroxidation (LPO), the proteomic profile, the cell death nature by cytotoxicity and apoptosis, and the Purkinje cells density. The IHg exposure increased mercury levels in the cerebellum, reducing ACAP and increasing LPO. The proteomic approach revealed a total 419 proteins with different statuses of regulation, associated with different biological processes, such as synaptic signaling, energy metabolism and nervous system development, e.g., all these molecular changes are associated with increased cytotoxicity and apoptosis, with a neurodegenerative pattern on Purkinje cells layer and poor motor coordination and balance. In conclusion, all these findings feature a neurodegenerative process triggered by IHg in the cerebellum that culminated into motor functions deficits, which are associated with several molecular features and may be related to the clinical outcomes of people exposed to the toxicant.


Subject(s)
Cerebellum/drug effects , Cerebellum/metabolism , Mercury Poisoning, Nervous System/metabolism , Mercury/toxicity , Neurodegenerative Diseases/metabolism , Proteome/metabolism , Animals , Antioxidants/metabolism , Apoptosis/drug effects , Biomarkers/metabolism , Energy Metabolism/drug effects , Lipid Peroxidation/drug effects , Male , Methylmercury Compounds/toxicity , Motor Cortex/drug effects , Motor Cortex/metabolism , Peroxides/metabolism , Proteomics/methods , Purkinje Cells/drug effects , Purkinje Cells/metabolism , Rats , Rats, Wistar , Signal Transduction/drug effects
7.
Inflammopharmacology ; 28(6): 1553-1566, 2020 Dec.
Article in English | MEDLINE | ID: mdl-32959092

ABSTRACT

We aimed to elucidate the role of cortical and hippocampal dendritic spines on neurological deficits associated with hippocampal microgliosis, hippocampal neurogenesis, and neuroinflammation in mice with cortical compact impact (CCI) injury. In the present study, we found that CCI reduced spatial memory mean latency (10 s. vs 50 s) and motor dysfunction (130 s. vs 150 s.) in mice, as determined by Morris water maze and rotarod test, respectively. Golgi staining of cortical pyramidal neurons revealed that, compared to the controls, the CCI group treated with vehicle solution had significantly lower values of dendritic order (or dendritic branch number) (4.0 vs 6.2), total spine length (400 µm vs 620 µm) and spine density (40 spines/µm vs 60 spines/µm), but had significantly higher values of dendritic beading (40 beadings/mm vs 20 beadings/mm). Additionally, Sholl analysis showed that, compared to controls, the CCI + NS group mice had significantly lower values of dendritic intersections (1.0 vs 2.0). Immunofluorescence assay also revealed that, compared to controls, the CCI + NS group mice had significantly higher values of the newly formed hippocampal cells (1250/mm2 vs 1000/mm2) but significantly lower values of dendritic order (2.0 branch # vs 4.2 branch #), total spine length (180 µm vs 320 µm) and intersection (1.0 vs 3.0). The CCI + NS group mice further showed significantly higher numbers of microglia in the dentate gyrus of the hippocampus and higher concentrations of pro-inflammatory cytokines in the cerebrospinal fluids. All the CCI-induced spatial memory (40 s) and motor (150 s) dysfunction, deranged dendritic and spine morphology of cortical pyramidal neurons or hippocampal newly formed cells, hippocampal microgliosis, and central neuroinflammation were all significantly reduced by melatonin administration during post-CCI. Simultaneously, melatonin therapy caused an enhancement in the compensatory hippocampal neurogenesis and neurotrophic growth factors (e.g., doublecortin-1) and compensatory central anti-inflammatory cytokines. Our results indicate that melatonin attenuates the spatial memory and motor deficits via the modification of cortical and hippocampal dendritic spine morphology, hippocampal microgliosis and neurogenesis, and neuroinflammation in mice with traumatic brain injury.


Subject(s)
Brain Injuries, Traumatic/drug therapy , Dendritic Spines/drug effects , Hippocampus/drug effects , Melatonin/pharmacology , Motor Cortex/drug effects , Neurons/drug effects , Spatial Memory/drug effects , Animals , Disease Models, Animal , Male , Maze Learning/drug effects , Mice , Mice, Inbred C57BL
8.
Biol Pharm Bull ; 43(9): 1356-1360, 2020.
Article in English | MEDLINE | ID: mdl-32879209

ABSTRACT

Polyherbal medicines are composed of multiple herbs and have traditionally been used in East Asian countries for the remedy of physiological symptoms. Although the effects of polyherbal formulations have been investigated at the molecular and behavioral levels, less is known about whether and how medicinal herbs affect the central nervous system in terms of neurophysiology. We introduced a novel blended herbal formulation that consisted of 35% linden, 21% mulberry, 20% lavandin, 20% butterfly pea, and 4% tulsi. After intraperitoneal administration of this formulation or saline, we simultaneously recorded epidural electrocorticograms (ECoGs) from the olfactory bulb (OB), primary somatosensory cortex (S1), and primary motor cortex (M1), along with electromyograms (EMGs) and electrocardiograms (ECGs), of rats exploring an open field arena. Using the EMGs and OB ECoGs, we segmented the behavioral states of rats into active awake, quiet awake, and sleeping states. Compared to saline, herbal medicine significantly shortened the total sleep time. Moreover, we converted the ECoG signal into a frequency domain using a fast Fourier transform (FFT) and calculated the powers at various ECoG oscillation frequencies. In the sleeping state, a slow component (0.5-3 Hz) of S1 ECoGs was significantly enhanced following the administration of the formulation, which suggests a region- and frequency-specific modulation of extracellular field oscillations by the polyherbal medicine.


Subject(s)
Brain Waves/drug effects , Plant Extracts/administration & dosage , Sleep/drug effects , Animals , Behavior, Animal/drug effects , Behavior, Animal/physiology , Brain Waves/physiology , Electrocorticography/instrumentation , Electrocorticography/methods , Electrodes, Implanted , Electromyography , Injections, Intraperitoneal , Male , Models, Animal , Morus/chemistry , Motor Cortex/drug effects , Motor Cortex/physiology , Olfactory Bulb/drug effects , Olfactory Bulb/physiology , Rats , Sleep/physiology , Somatosensory Cortex/drug effects , Somatosensory Cortex/physiology , Stereotaxic Techniques , Tilia/chemistry , Time Factors , Wakefulness/physiology , Wisteria
9.
Eur Neuropsychopharmacol ; 38: 63-72, 2020 09.
Article in English | MEDLINE | ID: mdl-32768154

ABSTRACT

Transcranial direct current stimulation (tDCS) induces polarity-dependent neuroplasticity: with conventional protocols, anodal tDCS results in excitability enhancement while cathodal stimulation reduces excitability. However, partially non-linear responses are observed with increased stimulation intensity and/or duration. Cathodal tDCS with 2 mA for 20 min reverses the excitability-diminishing plasticity induced by stimulation with 1 mA into excitation, while cathodal tDCS with 3 mA again results in excitability diminution. Since tDCS generates NMDA receptor-dependent neuroplasticity, such non-linearity could be explained by different levels of calcium concentration changes, which have been demonstrated in animal models to control for the directionality of plasticity. In this study, we tested the calcium dependency of non-linear cortical plasticity induced by cathodal tDCS in human subjects in a placebo controlled, double-blind and randomized design. The calcium channel blocker flunarizine was applied in low (2.5 mg), medium (5 mg) or high (10 mg) dosages before 20 min cathodal motor cortex tDCS with 3 mA in 12 young healthy subjects. After-effects of stimulation were monitored with TMS-induced motor evoked potentials (MEPs) until 2 h after stimulation. The results show that motor cortical excitability-diminishing after-effects of stimulation were unchanged, diminished, or converted to excitability enhancement with low, medium and high dosages of flunarizine. These results suggest a calcium-dependency of the directionality of tDCS-induced neuroplasticity, which may have relevant implications for future basic and clinical research.


Subject(s)
Calcium Channel Blockers/pharmacology , Calcium Channels/physiology , Evoked Potentials, Motor/physiology , Motor Cortex/physiology , Neuronal Plasticity/physiology , Transcranial Direct Current Stimulation/methods , Adult , Cross-Over Studies , Dose-Response Relationship, Drug , Double-Blind Method , Electrodes , Evoked Potentials, Motor/drug effects , Female , Humans , Male , Motor Cortex/drug effects , Neuronal Plasticity/drug effects , Transcranial Direct Current Stimulation/instrumentation , Young Adult
10.
Neuropharmacology ; 178: 108250, 2020 11 01.
Article in English | MEDLINE | ID: mdl-32726599

ABSTRACT

Volitional control is at the core of brain-machine interfaces (BMI) adaptation and neuroprosthetic-driven learning to restore motor function for disabled patients, but neuroplasticity changes and neuromodulation underlying volitional control of neuroprosthetic learning are largely unexplored. To better study volitional control at annotated neural population, we have developed an operant neuroprosthetic task with closed-loop feedback system by volitional conditioning of population calcium signal in the M1 cortex using fiber photometry recording. Importantly, volitional conditioning of the population calcium signal in M1 neurons did not improve within-session adaptation, but specifically enhanced across-session neuroprosthetic skill learning with reduced time-to-target and the time to complete 50 successful trials. With brain-behavior causality of the neuroprosthetic paradigm, we revealed that proficiency of neuroprosthetic learning by volitional conditioning of calcium signal was associated with the stable representational (plasticity) mapping in M1 neurons with the reduced calcium peak. Furthermore, pharmacological blockade of adenosine A2A receptors facilitated volitional conditioning of neuroprosthetic learning and converted an ineffective volitional conditioning protocol to be the effective for neuroprosthetic learning. These findings may help to harness neuroplasticity for better volitional control of neuroprosthetic training and suggest a novel pharmacological strategy to improve neuroprosthetic learning in BMI adaptation by targeting striatal A2A receptors.


Subject(s)
Adenosine A2 Receptor Antagonists/pharmacology , Calcium Signaling/physiology , Implantable Neurostimulators , Learning/physiology , Motor Cortex/metabolism , Receptor, Adenosine A2A/metabolism , Volition/physiology , Animals , Brain-Computer Interfaces , Calcium Signaling/drug effects , Learning/drug effects , Mice , Mice, Inbred C57BL , Motor Cortex/drug effects , Neurons/drug effects , Neurons/metabolism , Photometry/instrumentation , Photometry/methods , Purines/pharmacology , Volition/drug effects
11.
Elife ; 92020 05 19.
Article in English | MEDLINE | ID: mdl-32425158

ABSTRACT

Acetylcholine is well-understood to enhance cortical sensory responses and perceptual sensitivity in aroused or attentive states. Yet little is known about cholinergic influences on motor cortical regions. Here we use the quantifiable nature of birdsong to investigate how acetylcholine modulates the cortical (pallial) premotor nucleus HVC and shapes vocal output. We found that dialyzing the cholinergic agonist carbachol into HVC increased the pitch, amplitude, tempo and stereotypy of song, similar to the natural invigoration of song that occurs when males direct their songs to females. These carbachol-induced effects were associated with increased neural activity in HVC and occurred independently of basal ganglia circuitry. Moreover, we discovered that the normal invigoration of female-directed song was also accompanied by increased HVC activity and was attenuated by blocking muscarinic acetylcholine receptors. These results indicate that, analogous to its influence on sensory systems, acetylcholine can act directly on cortical premotor circuitry to adaptively shape behavior.


Subject(s)
Acetylcholine/metabolism , Cholinergic Neurons/metabolism , Motor Cortex/metabolism , Songbirds/metabolism , Vocalization, Animal , Animals , Atropine/pharmacology , Carbachol/pharmacology , Cholinergic Agonists/pharmacology , Cholinergic Neurons/drug effects , Female , Male , Motor Cortex/drug effects , Muscarinic Antagonists/pharmacology , Sexual Behavior, Animal , Social Behavior , Vocalization, Animal/drug effects
12.
Nat Neurosci ; 23(4): 533-543, 2020 04.
Article in English | MEDLINE | ID: mdl-32203497

ABSTRACT

Learning disabilities are hallmarks of congenital conditions caused by prenatal exposure to harmful agents. These include fetal alcohol spectrum disorders (FASDs) with a wide range of cognitive deficiencies, including impaired motor skill development. Although these effects have been well characterized, the molecular effects that bring about these behavioral consequences remain to be determined. We previously found that the acute molecular responses to alcohol in the embryonic brain are stochastic, varying among neural progenitor cells. However, the pathophysiological consequences stemming from these heterogeneous responses remain unknown. Here we show that acute responses to alcohol in progenitor cells altered gene expression in their descendant neurons. Among the altered genes, an increase of the calcium-activated potassium channel Kcnn2 in the motor cortex correlated with motor learning deficits in a mouse model of FASD. Pharmacologic blockade of Kcnn2 improves these learning deficits, suggesting Kcnn2 blockers as a new intervention for learning disabilities in FASD.


Subject(s)
Behavior, Animal/drug effects , Fetal Alcohol Spectrum Disorders/drug therapy , Learning Disabilities/drug therapy , Learning/drug effects , Motor Cortex/drug effects , Scorpion Venoms/pharmacology , Small-Conductance Calcium-Activated Potassium Channels/antagonists & inhibitors , Animals , Cell Shape/drug effects , Dendrites/drug effects , Dendrites/metabolism , Disease Models, Animal , Learning Disabilities/metabolism , Mice , Motor Activity/drug effects , Motor Cortex/metabolism , Neurons/drug effects , Neurons/metabolism , Scorpion Venoms/therapeutic use , Small-Conductance Calcium-Activated Potassium Channels/metabolism
13.
Exp Physiol ; 105(4): 690-706, 2020 04.
Article in English | MEDLINE | ID: mdl-32092208

ABSTRACT

NEW FINDINGS: What is the central question of the study? What are the effects of caffeine on neuromuscular function in a non-fatigued state and during fatiguing exercise? What is the main finding and its importance? In a non-fatigued state, caffeine decreased the duration of the silent period evoked by transcranial magnetic stimulation. Caffeine-induced reduction of inhibitory mechanisms in the central nervous system before exercise was associated with an increased performance. Individuals who benefit from caffeine ingestion may experience lower perception of effort during exercise and an accelerated recovery of M-wave amplitude postfatigue. This study elucidates the mechanisms of action of caffeine and demonstrates that inter-individual variability of its effects on neuromuscular function is a fruitful area for further work. ABSTRACT: Caffeine enhances exercise performance, but its mechanisms of action remain unclear. In this study, we investigated its effects on neuromuscular function in a non-fatigued state and during fatiguing exercise. Eighteen men participated in this randomized, double-blind, placebo-controlled crossover trial. Baseline measures included plantarflexion force, drop jump, squat jump, voluntary activation of triceps surae muscle, soleus muscle contractile properties, M-wave, α-motoneuron excitability (H-reflex), corticospinal excitability, short-interval intracortical inhibition, intracortical facilitation, silent period evoked by transcranial magnetic stimulation (SP) and plasma potassium and caffeine concentrations. Immediately after baseline testing, participants ingested caffeine (6 mg·kg-1 ) or placebo. After a 1-h rest, baseline measures were repeated, followed by a fatiguing stretch-shortening cycle exercise (sets of 40 bilateral rebound jumps on a sledge apparatus) until task failure. Neuromuscular testing was carried out throughout the fatigue protocol and afterwards. Caffeine enhanced drop jump height (by 4.2%) and decreased the SP (by 12.6%) in a non-fatigued state. A caffeine-related decrease in SP and short-interval intracortical inhibition before the fatiguing activity was associated with an increased time to task failure. The participants who benefitted from an improved performance on the caffeine day reported a significantly lower sense of effort during exercise and had an accelerated postexercise recovery of M-wave amplitude. Caffeine modulates inhibitory mechanisms of the CNS, recovery of M-wave amplitude and perception of effort. This study lays the groundwork for future examinations of differences in caffeine-induced neuromuscular changes between those who are deemed to benefit from caffeine ingestion and those who are not.


Subject(s)
Caffeine/administration & dosage , Exercise/physiology , Muscle Fatigue/drug effects , Neuromuscular Agents/administration & dosage , Adult , Double-Blind Method , Evoked Potentials, Motor/drug effects , Evoked Potentials, Motor/physiology , H-Reflex/drug effects , H-Reflex/physiology , Humans , Male , Motor Cortex/drug effects , Motor Cortex/physiology , Motor Neurons/drug effects , Motor Neurons/physiology , Muscle Contraction/drug effects , Muscle Contraction/physiology , Muscle Fatigue/physiology , Posture/physiology , Transcranial Magnetic Stimulation/methods
15.
Cereb Cortex ; 30(5): 2972-2985, 2020 05 14.
Article in English | MEDLINE | ID: mdl-31821409

ABSTRACT

Consistent body of evidence shows that transcranial direct-current stimulation (tDCS) over the primary motor cortex (M1) facilitates motor learning and promotes recovery after stroke. However, the knowledge of molecular mechanisms behind tDCS effects needs to be deepened for a more rational use of this technique in clinical settings. Here we characterized the effects of anodal tDCS of M1, focusing on its impact on glutamatergic synaptic transmission and plasticity. Mice subjected to tDCS displayed increased long-term potentiation (LTP) and enhanced basal synaptic transmission at layer II/III horizontal connections. They performed better than sham-stimulated mice in the single-pellet reaching task and exhibited increased forelimb strength. Dendritic spine density of layer II/III pyramidal neurons was also increased by tDCS. At molecular level, tDCS enhanced: 1) BDNF expression, 2) phosphorylation of CREB, CaMKII, and GluA1, and 3) S-nitrosylation of GluA1 and HDAC2. Blockade of nitric oxide synthesis by L-NAME prevented the tDCS-induced enhancement of GluA1 phosphorylation at Ser831 and BDNF levels, as well as of miniature excitatory postsynaptic current (mEPSC) frequency, LTP and reaching performance. Collectively, these findings demonstrate that anodal tDCS engages plasticity mechanisms in the M1 and highlight a role for nitric oxide (NO) as a novel mediator of tDCS effects.


Subject(s)
Motor Cortex/physiology , Neuronal Plasticity/physiology , Nitric Oxide/physiology , Signal Transduction/physiology , Transcranial Direct Current Stimulation/methods , Animals , Electrodes , Male , Mice , Mice, Inbred C57BL , Motor Cortex/drug effects , NG-Nitroarginine Methyl Ester/pharmacology , Neuronal Plasticity/drug effects , Nitric Oxide/antagonists & inhibitors , Organ Culture Techniques , Signal Transduction/drug effects
16.
Arch Ital Biol ; 157(2-3): 51-58, 2019 Sep 30.
Article in English | MEDLINE | ID: mdl-31821528

ABSTRACT

Recording synaptic activity of layer III neurons from motor cortex slices, which was provoked by stimulating layer IV, generated synaptic responses of the field potential (FP) that went from mean 100 µV to 600 µV when the stimulus was increased up to twice the threshold. Administering 100 µM or 200 µM of copper, increased the responses to mean 800 µV and 820 µV, respectively. The response to 200 µM was not significantly greater than that to 100 µM. However, all FP responses were significantly lower to a copper concentration of 500 µM. The basal FP was slowly restored by removing the copper with Krebs-Ringer(K-R), resulting in similar characteristics to those observed before copper administration. Then, neurons were perfused with penicillin (2000 UI) to increase cortical excitability and to assess the depressing effect of high concentrations of copper. Administering 500 µM of copper significantly reduced the activity generated by penicillin, while removing by wash(K-R) penicillin and copper generated FP responses similar to those obtained at baseline. Our data indicate that depending on the concentration, copper can behave as an activating or blocking agent for cortical activity.


Subject(s)
Anti-Bacterial Agents , Copper , Motor Cortex , Motor Neurons , Penicillin G , Animals , Anti-Bacterial Agents/pharmacology , Copper/pharmacology , Motor Cortex/drug effects , Penicillin G/pharmacology , Rats
17.
J Neurosci ; 39(43): 8484-8496, 2019 10 23.
Article in English | MEDLINE | ID: mdl-31582526

ABSTRACT

Neuromotor systems have the capacity for functional recovery following local damage. The literature suggests a possible role for the premotor cortex and cerebellum in motor recovery. However, the specific changes to interactions between these areas following damage remain unclear. Here, we demonstrate potential rewiring of connections from the ipsilesional ventral premotor cortex (ip-PMv) to cerebellar structures in a nonhuman primate model of primary motor cortex (M1) lesion and motor recovery. Cerebellar connections arising from the ip-PMv were investigated by comparing biotinylated dextran amine (BDA) between two groups of male Macaca mulatta: M1-lesion/motor recovery group and intact group. There were more BDA-labeled boutons and axons in all ipsilesional deep cerebellar nuclei (fastigial, interposed, and dentate) in the M1-lesion/recovery group than in the intact group. The difference was evident in the ipsilesional fastigial nucleus (ip-FN), and particularly observed in its middle, a putative somatosensory region of the ip-FN, which was characterized by absent or little expression of aldolase C. Some of the altered projections from the ip-PMv to ip-FN neurons were confirmed as functional because the synaptic markers, synaptophysin and vesicular glutamate transporter 1, were colocalized with BDA-labeled boutons. These results suggest that the adult primate brain after motor lesions can reorganize large-scale networks to enable motor recovery by enhancing sensorimotor coupling and motor commands via rewired fronto-cerebellar connections.SIGNIFICANCE STATEMENT Damaging the motor cortex causes motor deficits, which can be recovered over time. Such motor recovery may result from functional compensation in remaining neuromotor areas, including the ventral premotor cortex. We investigated compensatory changes in neural axonal outputs from ventral premotor to deep cerebellar nuclei in a monkey model of primary motor cortical lesion and motor recovery. The results showed an increase in premotor projections and synaptic formations in deep cerebellar nuclei, especially the sensorimotor region of the fastigial nucleus. Our results provide the first evidence that large-scale reorganization of fronto-cerebellar circuits may underlie functional recovery after motor cortical lesions.


Subject(s)
Cerebellum/physiopathology , Ibotenic Acid/toxicity , Motor Cortex/physiopathology , Nerve Net/physiopathology , Neuronal Plasticity/physiology , Recovery of Function/physiology , Animals , Cerebellum/drug effects , Macaca mulatta , Motor Cortex/drug effects , Nerve Net/drug effects
18.
Neurotox Res ; 35(3): 724-738, 2019 Apr.
Article in English | MEDLINE | ID: mdl-30443710

ABSTRACT

A widely held view suggests that homocysteine (Hcy) can contribute to neurodegeneration through promotion of oxidative stress. There is evidence that homocysteine is toxic to cerebellar Purkinje neurons in vitro; however, in vivo action of Hcy on Purkinje cell has not been investigated so far. Thus, this study was designed to evaluate the Hcy effects on neonatal rat cerebellum and cerebellar oxidative stress. We also evaluated the folic acid effects on biochemical alterations elicited by hyperhomocysteinemia (hHcy) in the cerebellum. Group I received normal saline, group II received Hcy subcutaneously twice a day at 8-h intervals (0.3-0.6 µmol/g body weight), group III received Hcy + folic acid (0.011 µmol/g body weight), and group IV received folic acid on postnatal day (PD) 4 until 25. On day 25, superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities in the cerebellum and motor cortex were assayed. Malondialdehyde (MDA) levels were also evaluated as a marker of lipid peroxidation. Rotarod and locomotor activity tests were performed in PD 25-27. Our results indicated that administration of Hcy increased plasma, cortical, and cerebellar total Hcy levels; reduced GPx activity; and induced lipid peroxidation in the cerebellum. Hcy impaired performance on the rotarod in rats. However, treatment with folic acid significantly attenuated motor coordination impairment, GPx activity reduction, the lipid peroxidation process, and significantly reduced plasma total Hcy levels. Histological analysis indicated that Hcy could decrease Purkinje cell count and folic acid prevented this toxic effect. We conclude that Hcy can induce neurotoxicity and folic acid has neuroprotective effects against cerebellar Hcy toxicity.


Subject(s)
Cerebellum/drug effects , Cerebellum/growth & development , Folic Acid/pharmacology , Homocysteine/adverse effects , Neuroprotective Agents/pharmacology , Animals , Antioxidants/pharmacology , Cerebellar Diseases/chemically induced , Cerebellar Diseases/drug therapy , Cerebellar Diseases/metabolism , Cerebellar Diseases/pathology , Cerebellum/metabolism , Cerebellum/pathology , Folic Acid/blood , Homocysteine/blood , Lipid Peroxidation/drug effects , Lipid Peroxidation/physiology , Male , Motor Cortex/drug effects , Motor Cortex/growth & development , Motor Cortex/metabolism , Motor Cortex/pathology , Neurodegenerative Diseases/chemically induced , Neurodegenerative Diseases/drug therapy , Neurodegenerative Diseases/metabolism , Neurodegenerative Diseases/pathology , Neuroprotective Agents/blood , Oxidative Stress/drug effects , Oxidative Stress/physiology , Random Allocation , Rats, Wistar
19.
Behav Brain Res ; 359: 81-88, 2019 02 01.
Article in English | MEDLINE | ID: mdl-30366033

ABSTRACT

Ischemic stroke is a major cause of disability and mortality worldwide, while no unequivocally efficacious drug is currently available to treat post-stroke functional impairments. Animal and clinical investigations suggest that the motor cortex stimulation constitutes a particularly promising approach for promoting function recovery after stroke. However, the cell types and mechanisms involved in stimulation-induced recovery are not well understood. Here, we used chemogenetic technique to selectively activate glutamatergic neurons in the primary motor cortex and investigated whether activation of glutamatergic neurons in the primary motor cortex can promote functional recovery after ischemic stroke in rats. The results showed that chemogenetic activation of the motor cortex glutamatergic neurons significantly decreased the neurological deficit scores, as well as significantly increased the grip test scores and the hanging time. Moreover, the glutamatergic neuronal activation also significantly decreased the escape latencies, increased the swimming speed, target quadrant time, and numbers of crossing platform position in the Morris water maze test. These results demonstrate that selective activation of the glutamatergic neurons in primary motor cortex is sufficient to promote functional recovery after ischemic stroke, and may be of importance in understanding the neural cellular mechanisms underlying the motor cortex stimulation-induced functional recovery.


Subject(s)
Brain Ischemia/physiopathology , Glutamic Acid/metabolism , Motor Cortex/physiopathology , Neurons/physiology , Recovery of Function/physiology , Stroke/physiopathology , Animals , Brain Ischemia/pathology , Disease Models, Animal , Genetic Techniques , Male , Motor Activity/physiology , Motor Cortex/drug effects , Motor Cortex/pathology , Neurons/drug effects , Neurons/pathology , Neurotransmitter Agents/pharmacology , Rats, Sprague-Dawley , Stroke/pathology
20.
Nutr Neurosci ; 22(8): 587-595, 2019 Aug.
Article in English | MEDLINE | ID: mdl-29286866

ABSTRACT

Although attention deficit hyperactivity disorder is associated with deficits in docosahexaenoic acid (DHA), an omega-3 fatty acid implicated in dopamine and glutamate synaptic plasticity, its role in neuroplastic brain changes that occur following repeated amphetamine (AMPH) treatment are not known. This study used pharmacological magnetic resonance imaging to investigate the impact of repeated AMPH exposure and alterations in brain DHA levels on AMPH-induced brain activation patterns. Male rats were fed a diet with no n-3 fatty acids (Deficient, DEF, n = 20), a diet fortified with preformed DHA (fish oil, FO, n = 20), or a control diet fortified with alpha-linolenic acid (n = 20) from P21 to P90. During adolescence (P40-60), one-half of each diet group received daily AMPH injections escalated weekly (0.5, 1.0, 2.5, 5.0 mg/kg/d) or drug vehicle. Following a 30-d abstinence period blood oxygen level dependent (BOLD) responses were determined in a 7 T Bruker Biospec system following an AMPH challenge (7.5 mg/kg, i.v). Postmortem erythrocyte and forebrain DHA composition were determined by gas chromatography. Compared with control rats, forebrain and erythrocyte DHA levels were significantly lower in DEF rats and significantly higher in FO rats. Across AMPH doses DEF rats exhibited greater locomotor activity compared to control and FO rats. In AMPH-naïve rats, the AMPH challenge increased BOLD activity in the substantia nigra and basal forebrain and no diet group differences were observed. In AMPH-pretreated control and FO rats, the AMPH challenge similarly increased BOLD activation in the bilateral caudate putamen, thalamus, and motor and cingulate cortices. In contrast, BOLD activation in AMPH-pretreated DEF rats was similar to AMPH-naïve DEF animals, and AMPH-pretreated DEF rats exhibited attenuated frontostriatal BOLD activation compared with AMPH-pretreated control and FO rats. These findings demonstrate that chronic escalating AMPH treatment induces enduring frontostriatal recruitment and that peri-adolescent deficits in brain DHA accrual impair this response.


Subject(s)
Amphetamine/administration & dosage , Brain/drug effects , Brain/physiology , Docosahexaenoic Acids/administration & dosage , Animals , Basal Forebrain/drug effects , Basal Forebrain/physiology , Corpus Striatum/drug effects , Corpus Striatum/physiology , Docosahexaenoic Acids/metabolism , Erythrocytes/metabolism , Gyrus Cinguli/drug effects , Gyrus Cinguli/physiology , Locomotion/drug effects , Magnetic Resonance Imaging , Male , Motor Cortex/drug effects , Motor Cortex/physiology , Prosencephalon/metabolism , Rats, Long-Evans , Substantia Nigra/drug effects , Substantia Nigra/physiology , Thalamus/drug effects , Thalamus/physiology
SELECTION OF CITATIONS
SEARCH DETAIL